Hepatobiliary Adverse Drug Reactions Associated With Remdesivir: The WHO International Pharmacovigilance Study.

Adenosine Monophosphate / analogs & derivatives Adverse Drug Reaction Reporting Systems Alanine / analogs & derivatives Databases, Factual Drug-Related Side Effects and Adverse Reactions / epidemiology Humans Pharmacovigilance SARS-CoV-2 World Health Organization COVID-19 Drug Treatment

Journal

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
ISSN: 1542-7714
Titre abrégé: Clin Gastroenterol Hepatol
Pays: United States
ID NLM: 101160775

Informations de publication

Date de publication:
09 2021
Historique:
received: 18 03 2021
revised: 22 04 2021
accepted: 27 04 2021
pubmed: 4 5 2021
medline: 24 8 2021
entrez: 3 5 2021
Statut: ppublish

Résumé

Remdesivir has demonstrated clinical benefits in randomized placebo-controlled trials (RCTs) in patients with coronavirus disease 2019 (COVID-19)

Identifiants

DOI: 10.1016/j.cgh.2021.04.039 PMID: 33940227
pubmed: 33940227
pii: S1542-3565(21)00496-1
doi: 10.1016/j.cgh.2021.04.039
pii:
doi:

Substances chimiques

remdesivir 3QKI37EEHE
Adenosine Monophosphate 415SHH325A
Alanine OF5P57N2ZX

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1970-1972.e3

Informations de copyright

Copyright © 2021 AGA Institute. Published by Elsevier Inc. All rights reserved.

Auteurs

Min Seo Kim (MS)

College of Medicine, Korea University, Seoul, Republic of Korea; Genomics and Digital Health, Samsung Advanced Institute for Health Sciences and Technology, Sungkyunkwan University, Seoul, Republic of Korea.

Se Yong Jung (SY)

Department of Pediatrics, Yonsei University College of Medicine, Seoul, Republic of Korea.

Seung Won Lee (SW)

Department of Data Science, Sejong University College of Software Convergence, Seoul, Republic of Korea.

Han Li (H)

University of Florida College of Medicine, Gainesville, Florida.

Ai Koyanagi (A)

Research and Development Unit, Parc Sanitari Sant Joan de Déu, Universitat de Barcelona, Fundació Sant Joan de Déu, CIBERSAM, Barcelona, Spain; ICREA, Pg. Lluis Companys 23, Barcelona, Spain; Instituto de Salud Carlos III, Centro de Investigación Biomédica en Red de Salud Mental, CIBERSAM, Madrid, Spain.

Andreas Kronbichler (A)

Department of Internal Medicine IV, Medical University Innsbruck, Innsbruck, Austria.

Elena Dragioti (E)

Pain and Rehabilitation Centre, Department of Health, Medicine and Caring Sciences, Linköping University, Linköping, Sweden.

Kalthoum Tizaoui (K)

Laboratory Microorganismes and Active Biomolecules, Sciences Faculty of Tunis, University Tunis El Manar, Tunis, Tunisia.

Paul Wasuwanich (P)

University of Florida College of Medicine, Gainesville, Florida.

Sung Hwi Hong (SH)

Yonsei University College of Medicine, Seoul, Republic of Korea.

Ramy Abou Ghayda (RA)

Urology Institute, University Hospitals System, Case Western Reserve University School of Medicine, Cleveland, Ohio.

Hae Won Yoo (HW)

Division of Gastroenterology and Hepatology, Soon Chun Hyang University Bucheon Hospital, Soonchunhyang University College of Medicine, Bucheon, Republic of Korea.

Hanna Kim (H)

College of Medicine, Ewha Womans University, Seoul, Republic of Korea.

Louis Jacob (L)

Research and Development Unit, Parc Sanitari Sant Joan de Déu, Universitat de Barcelona, Fundació Sant Joan de Déu, CIBERSAM, Barcelona, Spain; Faculty of Medicine, University of Versailles Saint-Quentin-en-Yvelines, Montigny-le-Bretonneux, France.

Joe-Elie Salem (JE)

Sorbonne Université, INSERM, CIC-1901 Paris-Est, CLIP(2) Galilée, UNICO-GRECO Cardio-oncology Program, and Department of Pharmacology, Pitié-Salpêtrière Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.

Karel Kostev (K)

University Clinic of Marburg, Marburg, Germany.

Youn Ho Shin (YH)

Department of Pediatrics, CHA Gangnam Medical Center, CHA University School of Medicine, Seoul, Republic of Korea.

So Young Kim (SY)

Department of Otorhinolaryngology-Head & Neck Surgery, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam, Republic of Korea.

Gabriele Gamerith (G)

Internal Medicine V, Department of Hematology and Oncology, Medical University Innsbruck, Innsbruck, Austria.

Dong Keon Yon (DK)

Department of Pediatrics, Seoul National University Children's Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea. Electronic address: yonkkang@gmail.com.

Jae Il Shin (JI)

Department of Pediatrics, Yonsei University College of Medicine, Seoul, Republic of Korea. Electronic address: shinji@yuhs.ac.

Lee Smith (L)

The Cambridge Centre for Sport and Exercise Sciences, Anglia Ruskin University, Cambridge, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Acides nucléiques, nucléotides et nucléosides › Nucléotides › Ribonucléotides › Nucléotides adényliques › AMP › Hepatobiliary Adverse Drug Reactions...
questionsmedicales.fr › Établissements, main d'oeuvre et services de soins de santé › Services de santé › Services pharmaceutiques › Services d'information sur les médicaments › Systèmes de signalement des effets indésirables des médicaments › Hepatobiliary Adverse Drug Reactions...
questionsmedicales.fr › Acides aminés, peptides et protéines › Acides aminés › Alanine › Hepatobiliary Adverse Drug Reactions...
questionsmedicales.fr › Sciences de l'information › Mémorisation et recherche des informations › Bases de données comme sujet › Bases de données factuelles › Hepatobiliary Adverse Drug Reactions...
questionsmedicales.fr › Troubles dus à des produits chimiques › Effets secondaires indésirables des médicaments › Hepatobiliary Adverse Drug Reactions...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Hepatobiliary Adverse Drug Reactions...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Mesures épidémiologiques › Pharmacovigilance › Hepatobiliary Adverse Drug Reactions...
questionsmedicales.fr › Virus › Virus à ARN › Virus à ARN à brin positif › Nidovirales › Coronaviridae › Coronavirus › Betacoronavirus › Virus du SRAS › SARS-CoV-2 › Hepatobiliary Adverse Drug Reactions...
questionsmedicales.fr › Organisations et économie des soins de santé › Organismes › Agences internationales › Nations Unies › Organisation mondiale de la santé › Hepatobiliary Adverse Drug Reactions...
questionsmedicales.fr › Thérapeutique › Traitement médicamenteux › Traitements médicamenteux de la COVID-19 › Hepatobiliary Adverse Drug Reactions...